Jim Cramer Commented on These 17 Stocks
On Friday, Mad Money host Jim Cramer shared his evolving view of Elon Musk’s company as he provided both praise and caution in light of recent developments involving Musk and President Donald Trump.
Novo Nordisk A S (NVO)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Was Jim Cramer Right About Novo Nordisk A/S (NVO)?
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other stocks that Jim Cramer...
Was Jim Cramer Right About These 9 Stocks?
During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies depend on China, during a time when the U.S.
BMO Capital Maintains Cautious Outlook on Novo Nordisk Amid CEO Transition
On May 19, BMO Capital Markets reaffirmed its "Market Perform" rating and $64.00 price target for Novo Nordisk A/S (NYSE:NVO) following the announcement of a CEO transition.
Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)'s competing medicine, Zepbound, the Danish pharmaceutical behemoth Novo Nordisk A/S (NYSE:NVO...
What Makes Novo Nordisk (NVO) a Lucrative Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Value Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Polen Focus Growth Strategy Exited Novo Nordisk A/S (NVO)
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 20245 investor letter. A copy of the letter can be downloaded here.
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will summarize the bulls’ thesis on NVO.
Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now
Domestic manufacturing in the pharmaceutical industry has fallen considerably in the last decades, with most active ingredient production moving to China and other countries.
15 Best Stocks to Buy According to Jim Simons' Renaissance Technologies
Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance Technologies, his quantitative...
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
